| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
ADAMTS like 2 | 0.666 | 0.346 | 1.6E-03 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
peptidase D | 0.621 | 0.769 | 1.5E-14 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 2006 | 2006 | ||||||||
|
tripartite motif containing 37 | 0.610 | 0.654 | 9.7E-12 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
cytochrome b-245 alpha chain | 0.520 | 0.769 | 8.9E-06 |
|
phenotype | 0.400 | None | 1.000 | 1 | 1 | 2017 | 2017 | ||||||||
|
solute carrier family 29 member 3 | 0.578 | 0.769 | 1.3E-07 |
|
phenotype | 0.400 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
nuclear receptor subfamily 1 group I member 3 | 0.448 | 0.846 | 3.5E-08 |
|
phenotype | 0.300 | None | 1.000 | 3 | 0 | 2013 | 2015 | ||||||||
|
leptin receptor | 0.433 | 0.808 | 0.99 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2012 | 2018 | ||||||||
|
aryl hydrocarbon receptor | 0.410 | 0.923 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 2 | 0 | 2016 | 2017 | ||||||||
|
cytochrome P450 family 1 subfamily A member 1 | 0.436 | 0.846 | 1.1E-17 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
cytochrome P450 family 1 subfamily A member 2 | 0.494 | 0.923 | 2.5E-10 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
cytochrome P450 family 1 subfamily B member 1 | 0.457 | 0.769 | 2.2E-05 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
somatomedin B and thrombospondin type 1 domain containing | 0.931 | 0.077 | 6.7E-06 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
ATP binding cassette subfamily C member 3 | 0.517 | 0.769 | 1.2E-26 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
G protein-coupled receptor 155 | 0.821 | 0.154 | 6.0E-16 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
Kruppel like factor 11 | 0.626 | 0.654 | 8.3E-09 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
COP9 signalosome subunit 3 | 0.729 | 0.346 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
mitogen-activated protein kinase 14 | 0.379 | 0.923 | 0.37 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
crystallin gamma D | 0.510 | 0.808 | 3.0E-04 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
histidine decarboxylase | 0.584 | 0.692 | 4.1E-03 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
myosin IB | 0.691 | 0.538 | 7.2E-05 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||
|
immunoglobulin kappa constant | 0.700 | 0.423 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
ADAM metallopeptidase domain 3A (pseudogene) | 0.792 | 0.231 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
RELA proto-oncogene, NF-kB subunit | 0.406 | 0.885 | 1.00 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 | ||||||||
|
nuclear receptor subfamily 5 group A member 2 | 0.563 | 0.731 | 0.24 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 |